Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Obsessive-Compulsive Disorder

tetradecanoylphorbol acetate has been researched along with Obsessive-Compulsive Disorder in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baroni, S; Cassano, GB; Dell'Osso, L; Di Nasso, E; Giannaccini, G; Lucacchini, A; Marazziti, D; Masala, I; Mungai, F; Presta, S1
Cassano, GB; Dell'Osso, L; Giannaccini, G; Hollander, E; Lucacchini, A; Marazziti, D; Masala, I; Mazzoni, MR; Presta, S; Rossi, A1

Trials

2 trial(s) available for tetradecanoylphorbol acetate and Obsessive-Compulsive Disorder

ArticleYear
Decreased inhibitory activity of PKC in OCD patients after six months of treatment.
    Psychoneuroendocrinology, 2002, Volume: 27, Issue:7

    Topics: Adolescent; Adult; Blood Platelets; Child; Enzyme Inhibitors; Female; Humans; Kinetics; Male; Obsessive-Compulsive Disorder; Protein Kinase C; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetradecanoylphorbol Acetate

2002
Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD.
    Neuropsychobiology, 2000, Volume: 41, Issue:4

    Topics: Adolescent; Adult; Biological Transport; Blood Platelets; Carcinogens; Carrier Proteins; Child; Enzyme Activation; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Protein Kinase C; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tetradecanoylphorbol Acetate

2000